ММВБ 4 248 -0,3%  Nasdaq 15 022 0,8%  Биткойн 61 888 -0,2%  USD/RUB 71,0668 -0,2% 
РТС 1 877 -0,8%  S&P500 4 486 0,3%  Нефть 84,5 0,4%  EUR/RUB 82,7345 0,0% 
Dow 35 259 -0,1%  FTSE100 7 204 -0,4%  Золото 1 773 0,5%  EUR/USD 1,1643 0,3% 

Dimerix Bioscience Ltd - Профиль

Dimerix Ltd. is a clinical stage biopharmaceutical company, which engages in the development of new therapeutic treatments identified using its proprietary drug discovery platform, Receptor-Heteromer Investigation Technology. Its lead therapy DMX-200 focuses on 2 chronic kidney disease sub indications, Focal Segmental Glomerulosclerosis, and Diabetic Kidney Disease. The firm also has therapeutic candidates for the treatment of liver inflammation; ocular or otology diseases; and allergy or inflammation. The company was founded on May 13, 1975 and is headquartered in Melbourne, Australia.

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент